Smith & Nephew plc (SNN)
NYSE: SNN · IEX Real-Time Price · USD
28.29
+0.10 (0.35%)
At close: Jul 19, 2024, 4:00 PM
28.30
+0.01 (0.04%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Smith & Nephew Employees
Smith & Nephew had 19,081 employees as of December 31, 2023. The number of employees decreased by 13 or -0.07% compared to the previous year.
Employees
19,081
Change (1Y)
-13
Growth (1Y)
-0.07%
Revenue / Employee
$290,813
Profits / Employee
$13,783
Market Cap
12.33B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19,081 | -13 | -0.07% |
Dec 31, 2022 | 19,094 | 118 | 0.62% |
Dec 31, 2021 | 18,976 | 395 | 2.13% |
Dec 31, 2020 | 18,581 | 551 | 3.06% |
Dec 31, 2019 | 18,030 | 1,349 | 8.09% |
Dec 31, 2018 | 16,681 | 348 | 2.13% |
Dec 31, 2017 | 16,333 | 749 | 4.81% |
Dec 31, 2016 | 15,584 | 898 | 6.11% |
Dec 31, 2015 | 14,686 | 1,218 | 9.04% |
Dec 31, 2014 | 13,468 | 2,432 | 22.04% |
Dec 31, 2013 | 11,036 | 559 | 5.34% |
Dec 31, 2012 | 10,477 | -266 | -2.48% |
Dec 31, 2011 | 10,743 | 571 | 5.61% |
Dec 31, 2010 | 10,172 | 408 | 4.18% |
Dec 31, 2009 | 9,764 | 7 | 0.07% |
Dec 31, 2008 | 9,757 | 567 | 6.17% |
Dec 31, 2007 | 9,190 | 360 | 4.08% |
Dec 31, 2006 | 8,830 | 212 | 2.46% |
Dec 31, 2005 | 8,618 | 752 | 9.56% |
Dec 31, 2004 | 7,866 | 415 | 5.57% |
Feb 16, 2003 | 7,451 | -55 | -0.73% |
Dec 31, 2002 | 7,506 | -420 | -5.30% |
Dec 31, 2001 | 7,926 | -2,509 | -24.04% |
Dec 31, 2000 | 10,435 | -778 | -6.94% |
Dec 31, 1999 | 11,213 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG & Co. KGaA | 119,845 |
Tenet Healthcare | 106,500 |
DaVita | 70,000 |
Dr. Reddy's Laboratories | 27,048 |
Charles River Laboratories International | 21,800 |
Medpace Holdings | 5,900 |
Natera | 3,293 |
Bio-Techne | 3,050 |
SNN News
- 8 days ago - Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins - CNBC
- 16 days ago - Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge - Benzinga
- 17 days ago - Smith & Nephew shares surge as activist Cevian Capital reveals 5% stake - Market Watch
- 3 months ago - Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia - GlobeNewsWire
- 3 months ago - Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE) - GlobeNewsWire
- 3 months ago - Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds - GlobeNewsWire
- 4 months ago - Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner - GlobeNewsWire
- 5 months ago - Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting - GlobeNewsWire